Sansei Capital Investment
VC Fund
Koto, Japan
Sansei Capital Investment is a VC fund in Koto focused on Content and Medical. Sansei Capital provides portfolio management, corporate management support, and financing services.
- Total investments:
- 50
- Last investment:
- Lead investor:
- 6%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Sansei Capital Investment invests in
Stages Sansei Capital Investment invests in
Countries Sansei Capital Investment invests in
Round sizes
Round size
- Series A
- $1.3M–$64M
- Series B
- $120k–$113M
Investment Focus
Industry
- Content 10 (20%)
- Medical 7 (14%)
- Marketing 7 (14%)
- Task Management 7 (14%)
- Software 6 (12%)
Stage
- Funding Round 23 (46%)
- Series A 7 (14%)
- Series B 6 (12%)
- Seed 5 (10%)
- Series D 3 (6%)
Country
- Japan 41 (82%)
- China 1 (2%)
- Belgium 1 (2%)
- Romania 1 (2%)
- United States 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
RABO
|
RABO is a Cat-Tech Company that "watches cat life with technology. | $5.5M / Series A / Apr 06, 2021 | |
Asoview
|
Asoview is an online booking website that provides booking services for tour, activities and attractions/experiences. | $184.3M / Series D / Dec 08, 2020 | |
MICOLY
|
MICOLY is a operator of a website aimed at publishing and selling creative video lessons. The company hosts lectures that are presented by the creators of all categories who are keen on sharing their techniques and philosophies in areas of nail art, Japanese calligraphy, flower arrangement, knitting and many more, as well as interacting with theirpassionate fans, enabling users to take creative lessons and start a new hobby. | $28.3M / Oct 30, 2020 | |
J-Pharma
|
J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where people with specific diseases are treated with novel and selective agents. J-Pharma’s intellectual property (IP) embraces the notion that cell membrane transporters are tightly associated to many diseases. Inaddition to drug molecules that target specific transporters, J-Pharma has discovered several important drug transporters within the human body that may be used to evaluate and optimize pharmacokinetics of new drug candidates. We believe that J-Pharma’s pipelines will lead to new agents and processes (i.e. diagnostic methods) and will increase the quality of life for an ageing population in industrialized countries. J-Pharma’s overall goal is to contribute globally to the maintenance of human health and improve human welfare through the creation of new drugs. | $234K / Series D / Jul 30, 2020 | |
Ginkan
|
GINKAN is the managing company of SynchroLife, the world's first restaurant recommendation platform where users and can earn cryptocurrency token rewards for dining out and posting restaurant reviews. GINKAN was selected for Plug and Play Japan Batch 1 in the fintech category and we won for best domestic fintech company and won the audienceaward at the Plug and Play Japan Batch 1 EXPO (Demo Day) in September 2018.GINKAN was also selected for Mitsubishi UFJ Financial Group’s MUFG Digital Accelerator’s Batch 4 and won the Grand Prix, Audience Award, and AWS Award in a triple win on their demo day on July 26, 2019. | $2.6M / Series A / Jun 02, 2020 | |
Galapagos
|
Galapagos offers a service that uses artificial intelligence to create and refine advertising visuals, under a product called AIR Design. The company also provides development and management for smartphone applications. | $2M / Seed / May 21, 2020 | |
TVISION INSIGHTS
|
TVISION INSIGHTS is a company that measures the "viewing quality" of television. Utilizing state-of-the-art human body recognition technology developed by TVISION, it is rare in the world to acquire TV viewing status in the living room and convert it into data, and a very unique data set that does not exist is founded It has been acquiredand accumulated since then. Currently, we have expanded our bases globally and have expanded to Tokyo, Boston and New York. While challenging challenges in different markets,we are continuing to grow rapidly to realize the original potential of TV. | $4.8M / Venture - Series Unknown / May 04, 2020 | |
atta
|
atta (formerlyWithTravel) is an accommodation metasearch service that recommends hundreds of hotels, apartments, and vacation rentals for your next holiday.We cover hotels and apartments in most holiday destination under one-site. Just search by entering your destination, dates, and number of guests. Sort your search results by price range, typeof accommodations, or amenities.WithTravel App is currently available in English, Japanese, Chinese, Korean, Thai, Malay, Indonesian, and Vietnamese. We cover major cities in Japan at the moment and will keep populating more accommodations for your discovery. | $3M / Series A / Jan 08, 2020 | |
Crunch Style
|
Crunch Style is a flower subscription service that makes it easy to make a flowery life.Deliver seasonal flowers from approximately 70 florists nationwide. Since it is delivered to the post in a special box, you can receive it even if you are away from work or going out. | $42.5M / Aug 08, 2019 | |
Crassone
|
Crassone is an housing assistance service. | $21.3M / Seed / Aug 01, 2019 | |
| See all 50 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Sansei Capital Investment invest in?
Sansei Capital Investment invests primarily in Content, Medical and Marketing startups, most often at Funding Round and Series A stage. Most of the 50 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sansei Capital Investment's check size?
Sansei Capital Investment typically joins rounds of $1.3M–$64M at Series A and $120k–$113M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sansei Capital Investment participates in.
When did Sansei Capital Investment last invest?
The most recent investment recorded for Sansei Capital Investment closed in Apr 2021. Shizune tracks 50 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
